≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

Malignant neoplasm of gallbladder

DOID Endpoint Browser

C3_GALLBLADDER

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

None

557745

2. Check conditions

None

557745

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 — C23&
  • Cause of death: ICD-9 — 1560
  • Cause of death: ICD-8 — 1560
  • Cancer registry: Topography ICD-O-3 — C23
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

2 out of 7 registries used, show all original rules.

212

4. Check minimum number of events

None

212

5. Include endpoints

None

212

6. Filter based on genotype QC (FinnGen only)

190

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF9

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 190 119 71
Unadjusted period prevalence (%) 0.04 0.04 0.03
Median age at first event (years) 73.23 73.01 73.60

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
195
Matched controls
1950
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C23
ICD-10 Finland
Malignant neoplasm of gallbladder
+∞
240.9
178
*
8140/3-C23.9
ICD-O-3
Adenocarcinoma, NOS, of gallbladder
+∞
141.4
118
*
130
Kela drug reimbursment
Malignant tumour
+∞
120.7
103
*
Z51.5
ICD-10 Finland
Palliative care
28.9
101.2
77
43
A03FA01
ATC
metoclopramide; systemic, rectal
14.5
81.6
109
157
WX302
NOMESCO Finland
Thoracal epidural anesthesy
33.1
65.2
44
17
H02AB02
ATC
dexamethasone; systemic
134.7
62.4
64
7
A04AA02
ATC
granisetron; systemic, transdermal
+∞
61.8
56
*
L01BC06
ATC
capecitabine; oral
+∞
59.5
54
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
57.1
52
*
UJK02
NOMESCO Finland
ERCP
24.8
57.1
43
22
A04AA01
ATC
ondansetron; systemic, rectal
23.0
54.1
42
23
N02AA05
ATC
oxycodone; systemic
8.5
50.1
100
216
JN4AD
NOMESCO Finland
Body CT examination
12.4
46.7
53
57
JKA20
NOMESCO Finland
Cholecystectomy
19.6
44.7
37
23
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
36.6
34
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
9.3
35.7
50
70
8000/3-C23.9
ICD-O-3
Neoplasm, malignant of gallbladder
+∞
35.5
33
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
93.7
35.3
38
5
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
12.8
34.1
36
34
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
15.1
34.0
32
25
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
33.3
31
*
JN4BD
NOMESCO Finland
Extensive body CT
11.3
32.9
38
41
WZC00
NOMESCO Finland
Treatment plan or consultation
5.1
27.9
91
286
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
49.2
27.8
33
8
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
10.2
27.1
33
38
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
26.7
25
*
K83.0
ICD-10 Finland
Cholangitis
58.7
26.1
30
6
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
285.0
25.3
25
*
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
5.7
24.9
57
131
JJB30
NOMESCO Finland
Excision of two segments of liver
+∞
24.5
23
*
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
34.5
21.2
27
9
JN3AD
NOMESCO Finland
Abdominal CT examination
5.3
20.5
50
120
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
82.0
20.1
22
*
JN4CD
NOMESCO Finland
Very extensive body CT
27.0
19.2
26
11
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
4.6
18.8
55
153
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
18.0
17
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
18.0
17
*
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
104.7
17.9
19
*
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
17.0
17.8
28
19
K83.1
ICD-10 Finland
Obstruction of bile duct
23.5
16.4
23
11
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
6.8
16.1
27
45
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
15.8
15
*
JJB10
NOMESCO Finland
Atypcal resection of liver
+∞
15.8
15
*
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
7.5
15.2
23
34
WZC30
NOMESCO Finland
Teaching
4.2
15.0
47
136
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
15.9
15.0
24
17
XX3DW
NOMESCO Finland
Time consuming IT work
7.3
14.8
23
35
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
14.8
14
*
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
+∞
14.8
14
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.3
13.4
39
106
A06AH03
ATC
naloxegol; oral
74.9
12.8
14
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.4
12.7
36
96
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
+∞
12.6
12
*
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
+∞
12.6
12
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.2
12.0
64
260
WX402
NOMESCO Finland
General anaesthesia
3.4
11.9
52
187
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
11.6
11
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
11.6
11
*
D77
ICPC
Malignant digestive neopl other/NOS
+∞
11.6
11
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
+∞
11.6
11
*
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
127.2
11.6
12
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.9
11.5
38
113
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
18.5
11.4
17
10
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
21.6
11.3
16
8
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
26.9
11.3
15
6
B01AB05
ATC
enoxaparin; parenteral
2.8
10.9
81
393
B01AB04
ATC
dalteparin; parenteral
5.6
10.1
20
39
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
58.0
9.7
11
*
ZX120
NOMESCO Finland
Intravenous
4.7
9.7
24
57
L03AA13
ATC
pegfilgrastim; parenteral
104.9
9.5
10
*
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
23.1
9.5
13
6
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
9.4
9
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
9.4
9
*
K82.9
ICD-10 Finland
Disease of gallbladder, unspecified
+∞
9.4
9
*
B01AB10
ATC
tinzaparin; parenteral
3.8
9.2
31
93
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
38.6
9.1
11
*
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
10.2
9.0
17
18
A07EC02
ATC
mesalazine; oral, rectal
5.0
8.8
20
44
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.4
8.8
36
123
JAH00
NOMESCO Finland
Laparotomy
12.4
8.7
15
13
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
94.0
8.5
9
*
8010/3-C23.9
ICD-O-3
Carcinoma, NOS, of gallbladder
+∞
8.4
8
*
K82.8
ICD-10 Finland
Other specified diseases of gallbladder
+∞
8.4
8
*
JK3FT
NOMESCO Finland
Exchange of bile duct catheter with radiological guidance
+∞
8.4
8
*
115
Kela drug reimbursment
Breast cancer
+∞
8.4
8
*
A04AD12
ATC
aprepitant; systemic
+∞
8.4
8
*
L02BG04
ATC
letrozole; oral
+∞
8.4
8
*
PJD99
NOMESCO Finland
Excision of other lymph nodes
+∞
8.4
8
*
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
7.4
8.3
19
28
ZXE30
NOMESCO Finland
More than five and less than seven hours
8.4
8.1
17
22
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
8.1
56
257
A05AA02
ATC
ursodeoxycholic acid; oral
12.6
7.7
13
11
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.7
7.7
52
235
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
7.3
7
*
A79
ICPC
Malignancy NOS
+∞
7.3
7
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
7.3
7
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
7.3
7
*
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
+∞
7.3
7
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
7.3
7
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.9
7.2
39
157
JKE12
NOMESCO Finland
Endoscopic extraction of calculus from bile duct
9.9
6.9
13
14
UJK12
NOMESCO Finland
Peroral cholangioscopy
41.5
6.8
8
*
K80.1
ICD-10 Finland
Calculus of gallbladder with other cholecystitis
6.9
6.8
16
25
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
23.5
6.7
9
*
K81.0
ICD-10 Finland
Acute cholecystitis
7.3
6.7
15
22
L03AA02
ATC
filgrastim; parenteral
72.1
6.5
7
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
6.3
6
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
6.3
6
*
JN3GE
NOMESCO Finland
Intraoperative ultrasound examination of abdomen
+∞
6.3
6
*
C24.09
ICD-10 Finland
Biliary duct or passage NOS
+∞
6.3
6
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
6.3
6
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
+∞
6.3
6
*

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
117
96
28.97
130.71
6.9
1.4
16.55
2.79
ug/l
1.79
111
77
54
15
49.40
89.16
3.2
1.7
677.82
249.42
u/ml
0.26
54
15
43
35
15.48
45.08
1.6
1.4
—
—
—
0
0
60
101
8.14
36.72
1.6
1.1
—
—
—
0
0
57
120
6.30
27.56
3.7
2.0
0.18
0.21
g/l
1.75
57
107
136
780
3.46
14.66
24.8
3.6
21.82
12.11
umol/l
1.66
136
729
45
135
4.03
13.60
5.9
5.7
6.15
11.01
mmol/l
6.59
45
125
91
429
3.10
13.45
6.1
4.0
—
—
—
0
0
91
448
2.93
12.18
3.0
2.0
—
—
—
0
0
114
646
2.84
11.51
3.6
2.3
—
—
estimate
—
0
0
15
7
23.05
10.86
1.3
1.0
—
—
—
0
0
129
798
2.82
10.70
14.1
15.1
1.20
1.31
inr
2.09
115
666
124
789
2.57
9.12
21.2
5.5
4.19
4.36
e9/l
0.36
117
665
82
455
2.38
7.84
3.0
1.6
—
—
—
0
0
48
215
2.64
7.18
1.8
1.7
—
—
—
0
0
29
664
0.34
7.13
2.3
2.0
1.14
1.28
mmol/l
0.72
23
550
30
106
3.16
6.89
1.5
1.3
—
—
—
0
0
64
345
2.27
6.31
1.5
1.2
—
—
—
0
0
18
48
4.03
6.25
2.8
1.6
60.94
35.61
u/ml
0.47
18
48
116
1456
0.50
5.13
4.9
5.7
5.94
6.06
mmol/l
0.70
106
1304
25
95
2.87
5.05
1.5
1.3
—
—
—
0
0
115
1429
0.52
4.49
5.2
5.7
4.80
4.53
mmol/l
1.62
100
1304
47
258
2.08
4.27
2.4
2.4
12.91
12.10
umol/l
0.31
47
235
115
1416
0.54
4.08
4.8
5.5
1.51
1.51
mmol/l
0.04
101
1285
120
1458
0.54
4.03
5.4
6.6
2.76
2.58
mmol/l
1.20
104
1324
111
836
1.76
3.65
6.6
5.7
1.19
1.22
mmol/l
2.56
96
731
6
6
10.26
3.52
3.7
1.8
2.42
6.67
nmol/l
—
6
6
117
1406
0.58
3.28
5.4
7.4
39.13
40.44
mmol/mol
0.85
103
1308
112
1361
0.58
3.28
4.4
4.6
1.27
1.26
mmol/l
0.06
99
1221
37
607
0.52
3.25
3.0
3.3
6.04
6.93
mmol/l
0.90
32
507
69
469
1.73
3.16
4.4
5.1
—
—
—
0
0
38
614
0.53
3.16
3.8
4.0
17.23
8.10
mg/mmol
0.27
13
374
37
602
0.52
3.14
2.8
3.3
87.58
48.46
mg/l
0.25
13
383
24
114
2.26
3.10
4.9
3.9
—
—
—
0
0
115
1381
0.59
3.10
4.8
5.8
2.01
1.94
mu/l
0.23
106
1260
73
507
1.70
3.08
3.4
3.3
7.41
7.40
ph
1.09
56
352
35
196
1.96
2.97
5.4
6.3
0.82
1.45
mmol/l
0.53
29
163
139
1154
1.71
2.89
27.7
5.3
154.75
76.25
u/l
8.39
139
1063
5
6
8.51
2.76
1.0
1.0
—
—
—
0
0
35
202
1.89
2.72
5.4
6.2
7.43
7.42
ph
0.31
16
122
0
70
0.00
2.65
0.0
1.4
—
7.92
—
0
16
5
7
7.29
2.56
1.4
1.4
23.36
14.68
ug/l
—
5
7
29
480
0.54
2.51
3.2
3.8
—
—
—
0
0
19
92
2.18
2.36
5.8
7.9
24.43
24.95
mmol/l
0.33
19
92
14
60
2.44
2.27
1.6
1.5
0.87
2.04
ug/l
0.83
14
51
5
9
5.67
2.22
1.0
1.2
—
—
—
0
0
8
26
3.16
2.03
1.6
2.0
3.81
4.67
e9/l
—
8
26
140
1559
0.64
2.01
53.3
23.6
120.74
133.13
g/l
17.11
140
1535
140
1559
0.64
2.01
52.9
23.3
30.22
30.30
pg
0.18
140
1536
140
1559
0.64
2.01
53.8
23.7
36.63
39.85
%
14.26
140
1536
140
1557
0.64
1.96
53.0
23.4
91.71
91.45
fl
0.22
140
1534
19
100
2.00
1.93
4.3
3.8
—
—
—
0
0
9
34
2.72
1.89
1.6
1.9
61.44
61.45
%
—
9
34
35
227
1.66
1.85
6.3
5.5
104.77
103.96
mmol/l
0.59
35
227
100
1180
0.69
1.82
3.9
4.5
15.44
15.06
pmol/l
0.66
92
1067
7
23
3.12
1.81
1.7
1.2
—
—
—
0
0
44
306
1.57
1.76
4.8
3.6
—
—
—
0
0
140
1546
0.67
1.71
47.2
21.0
72.36
78.97
umol/l
2.92
140
1520
19
105
1.90
1.70
6.1
7.9
1.24
1.32
%
0.14
19
105
20
113
1.86
1.68
3.1
3.0
1.50
0.76
%
0.48
14
25
64
809
0.69
1.64
2.1
2.2
94.18
96.95
pmol/l
0.23
41
377
103
1196
0.71
1.60
45.5
20.6
330.11
330.57
g/l
0.21
103
1190
58
437
1.47
1.59
15.6
4.3
—
—
—
0
0
56
420
1.47
1.57
2.7
3.1
—
0.00
estimate
—
0
5
90
737
1.41
1.57
6.3
4.8
0.64
0.59
e9/l
0.76
82
612
11
51
2.23
1.53
1.8
1.2
—
—
—
0
0
7
27
2.65
1.53
2.3
2.5
—
—
—
0
0
91
752
1.39
1.48
6.4
4.9
1.59
1.79
e9/l
1.56
84
645
18
103
1.82
1.46
6.4
7.9
0.72
0.67
%
0.23
18
103
92
765
1.38
1.43
6.3
4.9
0.16
0.20
e9/l
1.47
85
645
90
747
1.38
1.41
6.3
4.8
0.04
0.04
e9/l
0.18
81
618
59
456
1.42
1.40
2.7
3.1
0.56
0.45
e6/l
0.20
49
328
18
105
1.79
1.38
3.3
2.9
1.08
0.30
%
0.78
13
23
6
23
2.66
1.38
1.5
3.6
—
—
—
0
0
5
17
2.99
1.36
1.4
1.0
—
—
—
0
0
59
460
1.41
1.33
4.7
4.2
0.00
0.00
estimate
-0.00
26
151
135
1480
0.71
1.31
32.8
14.3
—
—
—
0
0
22
139
1.66
1.30
5.6
7.2
—
—
—
0
0
5
119
0.41
1.29
1.8
2.6
—
10.88
—
0
8
140
1516
0.73
1.14
31.3
10.6
33.88
23.65
u/l
6.74
140
1454
7
133
0.51
1.03
1.3
2.4
0.89
0.25
e6/l
—
7
122
7
134
0.50
1.03
1.3
1.5
—
—
—
0
0
26
182
1.49
1.03
3.1
2.0
372.08
140.73
ug/g
0.59
26
138
5
102
0.48
0.92
3.0
2.5
0.48
0.60
%
—
5
102
5
103
0.47
0.92
3.0
2.5
1.02
1.21
%
—
5
103
5
104
0.47
0.92
1.0
1.4
—
45.88
—
0
10
63
525
1.30
0.89
2.7
3.2
56.17
161.09
e6/l
0.38
53
393
10
58
1.76
0.81
1.1
1.3
—
—
—
0
0
7
121
0.56
0.81
1.9
1.5
—
—
—
0
0
47
382
1.30
0.80
1.5
1.8
471.51
445.42
pmol/l
0.32
39
301
0
27
0.00
0.78
0.0
1.1
—
1.53
—
0
27
46
555
0.78
0.76
1.7
1.8
19.50
20.21
nmol/l
0.12
41
469
5
25
2.03
0.73
1.4
1.4
—
—
nmol/l
—
0
0
12
180
0.64
0.72
2.7
2.4
1.52
7.65
ug/l
2.95
12
156
31
241
1.34
0.72
1.5
1.7
31.76
29.09
s
0.95
31
233
5
27
1.87
0.69
1.6
1.1
349.20
285.00
pmol/l
—
5
22
5
28
1.81
0.66
2.6
2.6
4.70
4.99
kpa
—
5
28
5
28
1.81
0.66
2.6
2.6
8.04
7.96
kpa
—
5
28
5
28
1.81
0.66
2.6
2.6
1.78
2.75
mmol/l
—
5
17
20
267
0.72
0.66
1.0
1.3
42.75
34.04
iu/ml
0.11
11
93
6
35
1.74
0.58
1.3
1.0
—
—
—
0
0
8
54
1.50
0.58
1.4
1.2
29.59
43.44
mg/l
—
8
49
8
54
1.50
0.58
1.4
1.2
24.48
31.35
mg/l
—
8
49
78
696
1.20
0.58
3.8
4.2
44.33
82.13
ng/l
0.32
64
535
17
124
1.41
0.58
1.2
1.4
—
—
—
0
0
38
452
0.80
0.55
2.6
3.4
—
0.11
—
0
18
15
108
1.42
0.55
3.6
3.1
0.20
0.00
%
—
10
18
16
117
1.40
0.54
1.8
1.2
—
—
—
0
0
6
96
0.61
0.53
3.0
4.4
1.01
1.02
ratio
—
6
91
19
245
0.75
0.52
1.1
1.3
46.73
14.63
u/ml
—
7
81
66
586
1.19
0.51
3.1
4.0
112.88
130.05
e6/l
0.13
53
408
52
452
1.21
0.50
3.9
3.8
0.00
0.00
estimate
-0.00
24
128
7
51
1.39
0.44
2.6
2.6
7.44
7.41
ph
—
7
51
70
633
1.17
0.43
4.5
4.2
0.00
0.04
estimate
0.78
22
137
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
2.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
71
645
1.16
0.41
25.5
10.4
0.00
0.00
e9/l
0.46
62
516
34
395
0.83
0.40
4.6
4.4
1.02
1.02
kg/l
0.05
26
270
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
65
588
1.16
0.40
3.2
3.6
—
—
—
0
0
5
79
0.62
0.36
1.0
1.2
—
112.64
—
0
27
24
285
0.82
0.35
1.7
1.3
1.95
2.56
g/l
1.76
17
142
11
82
1.36
0.35
1.3
1.2
—
—
—
0
0
18
216
0.82
0.30
2.3
2.9
0.84
0.81
ug/l
0.06
11
140
8
109
0.72
0.29
1.1
1.3
—
—
—
0
0
88
827
1.12
0.29
4.1
4.2
0.00
0.00
estimate
-0.00
30
168
13
104
1.27
0.27
3.1
2.4
4.57
5.22
kpa
1.74
13
99
31
350
0.86
0.27
1.4
1.6
1.12
1.30
mg/l
0.25
24
275
12
95
1.28
0.27
2.8
2.6
—
—
—
0
0
15
123
1.24
0.26
3.1
2.8
—
—
—
0
0
89
843
1.10
0.25
4.2
4.3
0.00
0.00
estimate
-0.00
32
176
22
190
1.18
0.24
1.2
1.5
—
—
—
0
0
89
847
1.09
0.22
4.3
4.3
0.00
0.01
estimate
0.50
30
168
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
12
99
1.23
0.20
2.8
2.5
7.41
7.41
ph
0.17
12
75
35
382
0.90
0.19
5.1
4.5
2.08
1.94
ug/l
0.14
27
336
5
66
0.75
0.17
1.2
1.3
—
—
—
0
0
6
79
0.75
0.16
1.2
2.6
14.78
16.62
nmol/l
—
6
72
9
79
1.15
0.15
2.3
3.3
36.96
36.92
°c
—
9
79
16
143
1.13
0.12
2.2
1.3
64.81
66.57
g/l
0.28
16
128
5
44
1.14
0.10
2.2
1.9
—
—
—
0
0
40
380
1.07
0.10
4.2
4.5
88.34
322.03
ng/l
1.37
29
335
5
46
1.09
0.09
1.8
1.7
111.60
127.84
g/l
—
5
32
6
57
1.05
0.08
3.8
3.3
1.18
1.58
mmol/l
—
6
57
24
225
1.08
0.08
1.5
1.3
—
—
—
0
0
18
192
0.93
0.05
2.8
3.3
7.42
7.39
ph
1.60
11
122
21
198
1.07
0.05
2.2
2.1
2.01
1.77
%
0.48
21
176
38
394
0.96
0.05
3.7
3.8
—
0.00
—
0
6
68
671
1.02
0.02
4.0
3.8
6.11
6.26
ph
0.45
40
372
19
196
0.97
0.00
1.6
1.7
—
—
—
0
0
15
146
1.03
0.00
2.3
1.2
—
—
—
0
0
20
196
1.02
0.00
1.6
1.3
128.00
546.67
titre
—
5
57
34
342
0.99
0.00
1.8
1.8
1257.00
1190.20
nmol/l
0.16
28
266
27
268
1.01
0.00
2.7
3.0
4.88
3.79
e6/l
0.11
13
124
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
1628.50
—
0
6
5
53
0.94
0.00
1.4
1.2
—
—
—
0
0
12
120
1.00
-0.00
1.1
1.2
—
—
—
0
0
7
79
0.88
-0.00
2.0
2.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
5
52
0.96
-0.00
4.4
3.3
6.54
7.86
mmol/l
—
5
52

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_GALLBLADDER – Malignant neoplasm of gallbladder

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).